Bulbul, M.V.; Mermer, A.; Kolbasi, B.; Kocabas, F.; Kalender, S.M.; Kirectepe Aydin, K.A.; Demircan, T.; Keskin, İ.
mTOR Pathway Inhibition, Anticancer Activity and In Silico Calculations of Novel Hydrazone Derivatives in Two- and Three-Dimensional Cultured Type 1 Endometrial Cancer Cells. Pharmaceuticals 2024, 17, 1562.
https://doi.org/10.3390/ph17121562
AMA Style
Bulbul MV, Mermer A, Kolbasi B, Kocabas F, Kalender SM, Kirectepe Aydin KA, Demircan T, Keskin İ.
mTOR Pathway Inhibition, Anticancer Activity and In Silico Calculations of Novel Hydrazone Derivatives in Two- and Three-Dimensional Cultured Type 1 Endometrial Cancer Cells. Pharmaceuticals. 2024; 17(12):1562.
https://doi.org/10.3390/ph17121562
Chicago/Turabian Style
Bulbul, Muhammet Volkan, Arif Mermer, Bircan Kolbasi, Fatih Kocabas, Semiha Mervenur Kalender, Kiymet Asli Kirectepe Aydin, Turan Demircan, and İlknur Keskin.
2024. "mTOR Pathway Inhibition, Anticancer Activity and In Silico Calculations of Novel Hydrazone Derivatives in Two- and Three-Dimensional Cultured Type 1 Endometrial Cancer Cells" Pharmaceuticals 17, no. 12: 1562.
https://doi.org/10.3390/ph17121562
APA Style
Bulbul, M. V., Mermer, A., Kolbasi, B., Kocabas, F., Kalender, S. M., Kirectepe Aydin, K. A., Demircan, T., & Keskin, İ.
(2024). mTOR Pathway Inhibition, Anticancer Activity and In Silico Calculations of Novel Hydrazone Derivatives in Two- and Three-Dimensional Cultured Type 1 Endometrial Cancer Cells. Pharmaceuticals, 17(12), 1562.
https://doi.org/10.3390/ph17121562
